Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: United Parcel Service, ServiceNow, CVS Health, Booking Holdings and Altria Group

Read MoreHide Full Article

For Immediate Release

Chicago, IL – September 23, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: United Parcel Service, Inc. (UPS - Free Report) , ServiceNow, Inc. (NOW - Free Report) , CVS Health Corporation (CVS - Free Report) , Booking Holdings Inc. (BKNG - Free Report) and Altria Group, Inc. (MO - Free Report) .

Here are highlights from Wednesday’s Analyst Blog:

Top Stock Reports for UPS, ServiceNow and CVS Health

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including United Parcel Service, ServiceNow, and CVS Health. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today's research reports here >>>

Shares of United Parcel Service have outperformed the Zacks Transportation - Air Freight and Cargo industry over the past year (+17.2% vs. +14.1%). The Zacks analyst appreciates UPS' efforts to reward its shareholders through dividends and buybacks and acknowledges the fact that the company paid out dividends worth $3.6 billion despite the coronavirus rout.

The company's board also approved a new share repurchase program worth $5 billion in August, while maintaining its pro-shareholder stance. UPS' solid liquidity position and an environment-friendly approach is also impressive. High operating expenses at UPS are a concern though.

(You can read the full research report on United Parcel Service here >>>)

ServiceNow shares have gained +38.5% in the last six months against the Zacks IT Services industry's gain of +18.7%. The Zacks analyst believes that its dominant position in the ITSM, ITOM markets, growing fortune 500 customer base, and product enhancements via strategic acquisitions are key catalysts for growth. 

ServiceNow has also been benefiting from a robust growth in subscription revenues. Based on strong adoption of its digital workflow solutions, it expects 2021 subscription billings to grow year over year. Stiff competition in non-ITSM product segments, as well as stretched valuation are major headwinds for the company.

(You can read the full research report on ServiceNow here >>>)

Shares of CVS Health have gained +1.7% in the past three months against the Zacks Retail Pharmacies and Drug Stores industry's loss of -2.2%. The Zacks analyst believes that an increasing demand for PBM and specialty pharmacy coupled with substantial growth in the retail business remain as key positives.

Second-quarter revenues across all three operating segments surpassed the company's expectations. Increased full-year guidance also reflects that this bullish trend is likely to continue throughout 2021. Pressure to reduce reimbursement rates for generic drugs, a dismal retail performance, and pressure on margins are some of the major headwinds though.

(You can read the full research report on CVS Health here >>>)

Other noteworthy reports we are featuring today include Booking Holdings and Altria Group.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Published in